Enteric fever is a global health problem. Around 21.6 million people are affected (incidence of 3.6 per 1000 population) with enteric fever which kills an estimated 200,000 people every year. The disease is endemic in Indian subcontinent, Southeast Asia, South and Central America and Africa. 1 Bangladesh being in this region and a country with poor sanitary infrastructure is endemic for enteric fever as other South Asian countries.
Enteric fever has been reported from almost every part of Bangladesh. It is a common cause of febrile illness among the patients presenting to medical facilities and also happens to be the major reason for seeking health service by the general population. Studies conducted in Bangladesh by ICDDR,B showed an incidence of approximately 2000 per 100 000 per year. 2 Chloramphenicol became the standard antibiotic for treating typhoid in 1948. 3 But in 1972, chloramphenicol-resistant typhoid fever became a major problem. 4 Several outbreaks occurred in Mexico, India, Vietnam, Thailand, Korea and Peru. 4 S. enterica serotype typhi strains were also resistant to sulfonamides, tetracycline and streptomycin, but initially amoxycillin and trimethoprimsulfamethoxazole remained effective alternative drugs. At the end of 1980s and 1990s, S. enterica serotype typhi developed resistance simultaneously to all the first-line drugs (chloramphenicol, trimethoprim, sulfamethoxazole and ampicillin). 4 Outbreaks of infections with these strains occurred in India, Pakistan, Bangladesh, Vietnam, the Middle East and Africa. 5 Third generation cephalosporins are now the mainstay of treatment of enteric fever. Isolation of S. typhi resistant to ceftriaxone from Bangladeshi population and reports of clinical strains with higher minimum inhibitory concentration (MIC) from India are increasing. Thus treatment options are getting limited. 6, 7 This situation highlights the need of continued surveillance for changing antibiotic sensitivity and resistance profile of Salmonella spp. over time so that physicians can choose the right antibiotic and prevent misuse of valuable drugs. 
Materials and Methods
This cross-sectional study was done in the department of Medicine of United Hospital Limited, Dhaka during October 2009-November 2010 and January-December 2012. Laboratory reports of blood culture were collected from those patients who were investigated as suspected cases of enteric fever. Both the indoor and outdoor patients were enrolled in the study. Data were processed and analyzed by rate, ratio and percentage.
Salmonella species resistant to one or more of the first line drugs (chloramphenical, cotrimoxazole and ampicillin) were divided into resistant strain, epidemic strain and multi-drug resistant strain. 8 Resistant strains of Salmonella were resistant to at least one of the first line drugs. Epidemic strains of Salmonella were resistant to chloramphenicol and cotrimoxazole but susceptible to ampicillin. Multidrug-resistant S. typhi (MDRST) is mainly reserved for strains resistant to all three first-line antityphoidal antimicrobial agents, namely ampicillin, chloramphenicol and cotrimoxazole. 
Results
During the period October 2009-November 2010, total 210 subjects were enrolled. Among the participants, 122 were male and 88 were female with a ratio of 1.3:1. During the period JanuaryDecember 2012, total 139 subjects were enrolled. Among the participants 68 were male and 71 were female with a ratio of 1:1.04. Age distribution of culture positive enteric fever subjects is shown in FigIntroduction During the period October 2009-November 2010, sensitivity was found 77% for ampicillin, 91.4% for cotrimoxazole, 78.6% for chloramphenicol, 87.6% for ciprofloxacin, 96.6% for cefixime, 98% for ceftriaxone and only 22.1% for azithromycin (77.9% resistant) (Table I) . During this period 91 (43.3%) cases were found having resistant strain, 6 (2.8%) epidemic strain and 8 (3.8%) MDR strain Salmonella spp. (Table II) . During the period January-December 2012, sensitivity was found 62.7% for ampicillin, 82% for cotrimoxazole, 83% for chloramphenicol, 45.2% for azithromycin, 95% for ciprofloxacin, 99.3% for cefixime and 100% for ceftriaxone (Table I) . During this period, there were 55 (39.6%) resistant strain, 3 (2.1%) epidemic strain and 17 (12.2%) MDR strain Salmonella spp. (Table II) . (Table III) . During the period between January-December 2012, 67.3% showed resistance in resistant strain, 33.3% in epidemic strain and 29.4% in MDR strain (Table III) .
Discussion
Typhoid fever is highly endemic in developing countries like Bangladesh and is an important cause of health problem involving huge health care costs, high morbidity and economic loss. Children are affected mostly between 5-12 years. 10 Atypical presentation of typhoid fever may be misdiagnosed in pre-school age group due to an underdeveloped reticuloendothelial system.
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In our study causative organisms of enteric fever were predominantly S. typhi followed by S. paratyphi. Shirakawa et al found S. paratyphi as the commonest cause of typhoid fever. 12 In this study Salmonella spp. remained sensitive to chloramphenicol, ampicillin, and cotrimoxazole over both study periods. The re-emergence of increased sensitivity of cotrimoxazole and chloramphenicol to Salmonella should be considered in using it as first line therapy. High susceptibility to chloramphenicol, cotrimoxazole, and ampicillin were also reported from several parts of India such as Bangaluru, Chennai, Chandigarh, central west, and northern India. 13 A study done by Chand et al 14 revealed reemergence of susceptibility to ampicillin, chloramphenicol and cotrimoxazole in great proportion.
Patients in Indian subcontinent or with the history of travel to the Indian subcontinent were suggested to receive ciprofloxacin as first line therapy. 15 But S. typhi isolates resistant to ciprofloxacin and ceftriaxone have been reported. S. typhi strains with reduced susceptibility to fluoroquinolones have become a major problem in Asia and other parts of the world. 16 In this study, sensitivity to ciprofloxacin increased from the first study period (87.6%) to the second (95%).
Optimal antimicrobial treatment of patients with enteric fever depends on an understanding of local patterns of antimicrobial resistance and is enhanced by the results of antimicrobial susceptibility testing of the Salmonella isolated from the individual patient. Third-generation cephalosporins such as ceftriaxone may be used. However, the cost and route of administration make ceftriaxone less suitable for treatment in some low-and middleincome countries, and the oral third-generation cephalosporin cefixime appears to be inferior to other oral agents both in terms of fever clearance time and treatment failure. 17 In this study, sensitivity to ceftriaxone was high in both periods. All the 139 isolates of January-December 2012 were sensitive to ceftriaxone which correlates with the study of Arora et al. 18 This underlies the importance of the drug for treating MDR and ciprofloxacin resistant enteric fever cases. Emphasis has to be laid on the sparing use of the drug to prevent the occurrence of resistance to ceftriaxone. WHO recommends the fluoroquinolones or cefixime for the treatment of MDR typhoid fever and azithromycin, the third-generation cephalosporins, or a 10-14 day course of high-dose older generation fluoroquinolones for the treatment of nalidixic acid resistant typhoid (NART). But in this study resistance of different strains of Salmonella to azithromycin is very high. Antibiotics are unnecessarily prescribed for infections such as the common cold, cough and diarrhea which are usually of viral etiology and can be resolved by the immune system. Emphasis is placed on treatment instead of finding the causative organism and reaching a proper diagnosis. This leads to patients being treated with broad spectrum antibiotics, which results in the emergence of MDR organisms. 15 A limitation of our study was that clinical outcomes were not analyzed. Quinolones may remain effective despite in vitro resistance and ceftriaxone may be associated with prolonged time to fever resolution despite in vitro sensitivity.
The policy of empirical treatment of enteric fever needs to be rationalized and newer generation antibiotics should be used only for multi-resistant cases of enteric fever. Consistent surveillance and antibiotic susceptibility testing is required in different parts of the country to know the sensitivity pattern among enteric fever pathogens, which will be helpful for clinicians for rational prescribing.
